Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia
- PMID: 24124828
- DOI: 10.1016/j.jaad.2013.07.025
Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia
Comment on
-
Pruritus in patients treated with targeted cancer therapies: systematic review and meta-analysis.J Am Acad Dermatol. 2013 Nov;69(5):708-720. doi: 10.1016/j.jaad.2013.06.038. Epub 2013 Aug 24. J Am Acad Dermatol. 2013. PMID: 23981682 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
